Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: A population-based study

The prevalence of coexistent diseases in addition to breast cancer becomes increasingly important in an ageing population. However, the clinical implications are unclear. The age-specific prevalence of serious comorbidity among all new breast cancer patients diagnosed from 1995 to 2001 ( n = 8966) i...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2005-03, Vol.41 (5), p.779-785
Main Authors: Louwman, W.J., Janssen-Heijnen, M.L.G., Houterman, S., Voogd, A.C., van der Sangen, M.J.C., Nieuwenhuijzen, G.A.P, Coebergh, J.W.W.
Format: Article
Language:English
Subjects:
Adult
Age Distribution
Aged
Aged, 80 and over
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Breast cancer
Breast Neoplasms - mortality
Breast Neoplasms - therapy
Combined Modality Therapy
Comorbidity
Elderly
Epidemiologic Methods
Female
Humans
Long-term prognosis
Lymph Node Excision - statistics & numerical data
Mastectomy, Segmental - statistics & numerical data
Medical sciences
Middle Aged
Netherlands - epidemiology
Pharmacology. Drug treatments
Prognosis
Treatment
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prevalence of coexistent diseases in addition to breast cancer becomes increasingly important in an ageing population. However, the clinical implications are unclear. The age-specific prevalence of serious comorbidity among all new breast cancer patients diagnosed from 1995 to 2001 ( n = 8966) in the South of the Netherlands was analysed in relation to age, stage and treatment. Independent prognostic effects of age and comorbidity were evaluated (follow-up was continued until 1 January 2004). The prevalence of comorbidity increased from 9% for those aged
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2004.12.025